GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Other Financing

IMGT (XKRX:456570) Other Financing : ₩-15.30 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Other Financing?

IMGT's Other Financing for the six months ended in Dec. 2023 was ₩-15.30 Mil.

IMGT's Other Financing for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-15.30 Mil.


IMGT Other Financing Historical Data

The historical data trend for IMGT's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Other Financing Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Financing
- - - -15.30

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Other Financing - - - -15.30

IMGT Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-15.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMGT Other Financing Related Terms

Thank you for viewing the detailed overview of IMGT's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


IMGT (XKRX:456570) Business Description

Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines